Venter says gene testing results show discrepancies

10/7/2009 | Bloomberg

Genetic testing firms such as Navigenics and 23andMe don't always agree when predicting an individual's risk for diseases based on the genetic makeup because they use different markers when making such predictions, genome pioneer J. Craig Venter and colleagues said in an opinion article in Nature. Companies could generate compatible genetic results by agreeing on a core set of markers, Venter said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA